Depression News

The spray gets to work in as little as two hours, far quicker than widely used medications that can take weeks to kick in.

A study led by scientists at Yale University has described the promising early-stage results of a new drug designed to mimic the rapid antidepressant effects of ...

DEAR DR. ROACH: I have persistent genital arousal disorder. I find it incredibly difficult to talk about with my doctors and I've been openly mocked for it.

Once deemed a "club drug," ketamine is now being touted as a treatment for depression.

Researchers at The Alfred Hospital in Melbourne are looking to explore the benefits of laughing gas as a treatment for depression. Participants are currently ...

According to the American Cancer Society, 15 to 28 percent of all breast cancer survivors will develop Breast.

Perhaps you've heard a lot of people are using CBD. The chemical compound, naturally occurring in cannabis plants, doesn't get you high, but does have a ...

A range of studies show that connections among social identification, perception, and interpretation of social situations affect quality of life in patients with major ...

Studies including more than 11 000 people worldwide were used to determine whether facial expressions can affect people's moods.

Participants will sit in a chair and inhale nitrous oxide for an hour at a time while they "relax and listen to nice music." Enrolments are now open.

It's almost three in the morning, and this column is about how I can't write this column. When I applied to be a columnist over winter break, high on codeine and ...

A new study offers a better understanding of the way ketamine helps lift depression symptoms.

My road to diagnosis is similar to others. Unfortunately I was knocking on deaths door before I had a diagnosis and I knew it, but no one believed me. Not my ...

Depression is a serious affliction that affects over 300 million people worldwide. In the U.S., one in eight Americans over age 12 takes an antidepressant.

Seelos Therapeutics (NASDAQ:SEEL) - The New York-based clinical-stage biopharmaceutical company has several drugs in the pipeline capable of generating ...

Seelos Therapeutics (NASDAQ:SEEL) - The New York-based clinical-stage biopharmaceutical company has several drugs in the pipeline capable of generating ...

Pharmacotherapies for cannabis use disorder have little evidence of efficacy, explains Dr Peter Yellowlees.

RESEARCH UPDATE. Dr Aiken is Director of the Mood Treatment Center, Editor in Chief, The Carlat Psychiatry Report, and Instructor in Clinical Psychiatry, ...

A new small-molecule drug produced a rapid antidepressant response similar to that of ketamine when tested in mice, a new Yale-led study published April 16 ...

NEW YORK, April 16, 2019 /PRNewswire/ -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment ...